Skip to main content
logo
Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.3476
-0.0083 (-2.33%)
At close: Oct 2, 2026, 4:00 PM EDT
0.3690
+0.0214 (6.16%)
After-hours: Oct 2, 2026, 7:56 PM EDT

Heron Therapeutics Revenue

Heron Therapeutics had revenue of $37.67M in the quarter ending June 30, 2026, with 1.25% growth. This brings the company's revenue in the last twelve months to $151.18M, up 0.99% year-over-year. In the year 2025, Heron Therapeutics had annual revenue of $154.90M with 7.36% growth.

Revenue (ttm)
$151.18M
Revenue Growth
+0.99%
P/S Ratio
0.44
Revenue / Employee
$1,181,078
Employees
128
Market Cap
65.99M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025154.90M10.62M7.36%
Dec 31, 2024144.29M17.24M13.57%
Dec 31, 2023127.04M19.37M17.99%
Dec 31, 2022107.67M21.33M24.70%
Dec 31, 202186.35M-2.29M-2.59%
Dec 31, 202088.64M-57.33M-39.28%
Dec 31, 2019145.97M68.49M88.41%
Dec 31, 201877.47M46.71M151.81%
Dec 31, 201730.77M29.49M2,305.55%
Dec 31, 20161.28M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011646.00K-655.00K-50.35%
Dec 31, 20101.30M40.00K3.17%
Dec 31, 20091.26M892.00K241.73%
Dec 31, 2008369.00K-43.00K-10.44%
Dec 31, 2007412.00K--
Dec 31, 2006---
Dec 31, 20055.39M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Champions Oncology60.66M
MindWalk Holdings11.57M
Alps Group3.74M
Connect Biopharma Holdings2.95M
Alterity Therapeutics2.50M
Revenue Rankings

HRTX News

More News